Archive for the 'International News' Category
March 25th, 2011 by admin
Novartis has completed its acquisition of 85% in the Chinese vaccines firm Zhejiang Tianyuan Bio-Pharmaceutical. The deal, roughly valued at $125 million, was first announced in November 2009. Swiss drugs giant Novartis has said that the acquisition will provide it with an expanded presence in the Chinese vaccines market and also facilitate the introduction of additional Novartis’ vaccines into the country. The firms claims that China represents the world’s third largest vaccines market, with annual industry sales of over $1 billion, and the expectation of double-digit growth over coming years.
Continue reading ‘Novartis Completes $125M Acquisition of Tianyuan’
March 24th, 2011 by admin
As workers battle against the radiation leakage from the now battered nuclear plant in northeastern Japan, civilians have fled the city of Tokyo including foreigners. People all over the world are drawing their attention towards public health officials out of fear. Health officials are turning towards potassium iodide pills to safeguard them from radiation, eluding the risks this medicine carries in the absence of a live nuclear threat.
Continue reading ‘Radiation from Fukushima Plant – High or Insignificant?’
March 21st, 2011 by admin
Many of the ads for “anti-radiation” potassium iodide pills flooding the Internet may be scams run by hucksters seeking to profit from the Japan nuclear scare, the Food and Drug Administration warned Thursday. “We found many different offers for potassium iodide and other products that we’re taking a look at,” says Gary Coody, the FDA’s national health fraud coordinator.
Continue reading ‘FDA Warns of Drug Scams that Play on Radiation Fear’
February 23rd, 2011 by admin
Pharmaceutical companies in India are growing at a very fast pace and this has made the Indian pharmaceutical industry as the second largest growing industry. Also the pharmaceutical industry in India is the third largest in the world, which will be of US$20 billion by 2015. Mergers and acquisitions are the part of this growth. The compounded annual growth rate of pharma in India is 12-15% and the global figures are 4-7% for the period of 2008-2013. With such a profound growth of pharmaceutical companies in India numerous pharmaceutical jobs can be seen. This in turn is helping biotechnology industry and booming the biotechnology jobs in India.
Continue reading ‘Pharmaceutical Industry in India, Top Pharma Companies and Jobs’
February 9th, 2011 by admin
India’s No.2 drugmaker Dr Reddy’s Laboratories Ltd said a U.S. district court has cleared the sale of its generic version of Sanofi-Aventis’ allergy medicine Allegra D24, sending its shares up nearly 4 percent. The U.S. District Court of New Jersey lifted an injunction passed last June against the Indian drugmaker from selling a copycat version of the drug, Dr Reddy’s said in a statement.
Continue reading ‘U.S. Court Clears Generic Allegra Sale’
February 8th, 2011 by admin
NPS Pharmaceuticals says that it’s on track to file for regulatory approval of Gattex after a late-stage study involving 86 patients demonstrated promising results for reducing the need for IV feeding among a majority of patients with short bowel syndrome. NPS now plans to file in the second half of the year and the news quickly spurred a 30 percent hike in its stock price in pre-market trading.
Continue reading ‘NPS Soars on Positive Ph3 Data for Orphan SBS Drug’
January 31st, 2011 by admin
Merck Serono is teaming up with France’s Domain Therapeutics to take aim at a new target for Parkinson’s and other neurodegenerative diseases. Domain will contribute compounds developed from their chemical series in exchange for a €2 million upfront, research funding and up to €132 million ($175 million) in milestones for the first two products.
Continue reading ‘Domain Gets $178M Deal to Develop Parkinson’s Drugs’
January 19th, 2011 by admin
Mosquirix, an experimental malaria vaccine from GlaxoSmithKline, provides African children with long-lasting protection and reduces the risk of infection by the parasite that causes severe malaria by 46 percent over 15 months, according to researchers.
Continue reading ‘GSK Malaria Vax Shows Promising Results’
December 31st, 2010 by admin
Novartis has submitted its meningococcal B vaccine Bexsero to the EU for marketing approval. “The Bexsero submission in the EU is an important milestone toward achieving the world’s first broad-coverage MenB vaccine through our unique multi-component approach,” said Andrin Oswald, head of Novartis Vaccines and Diagnostics Division. “Meningococcal disease is sudden and aggressive, leaving little time for treatment. Proactive vaccination of individuals has been shown to offer the best protection against fatal infectious diseases.
Continue reading ‘Novartis Files for Bexsero Approval’
December 27th, 2010 by admin
The emerging-markets gold rush continues. Drugmakers continued their race into those fast-growing, tantalizing new markets. India, China, Brazil, Russia, Mexico–all so alluring in a world in which countries that could once be counted on for steady increases are no longer delivering.
Continue reading ‘Big Pharma Still Big on Emerging Markets’
